NCT01805882View on ClinicalTrials.gov

Combination Therapy for Chronic Hepatitis C Infection

PHASE2CompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Hepatitis C, Chronic
Interventions
DRUG

Sofosbuvir

DRUG

Ledipasvir

DRUG

GS-9669

DRUG

GS-9451

Trial Locations (3)

20002

Unity Health Care, Inc./DC General, Washington D.C.

20020

Family Medical and Conseling Services, Washington D.C.

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01805882 - Combination Therapy for Chronic Hepatitis C Infection | Biotech Hunter | Biotech Hunter